oppn parties WHO Alert For Contaminated Syrups: India's Reputation As The Pharmacy Of The World Is At Stake

News Snippets

  • Allahabad HC said that the UP Police is acting as law unto themselves as they detained a person unlawfully even before his arrest
  • Kolkata witnesses traffic snarls on the first day of the Durga Puja festival as revellers start pnadal-hopping
  • Neha Bora was subsequently released and Dipke is to appear before a magistrate today at noon
  • Delhi Police detained Cockroach Janta Party founder Abhijeet Dipke, Neha Bora of AISA, student leaders and supporters ahead of a rally in Connaught Place demanding Chief Election Commissioner Gyanesh Kumar's resignation. The protest followed the detention and jailing of two CJP leaders earlier in the week over demonstrations at Jantar Mantar
  • The Reserve Bank of India is considering further monetary tightening to counter capital outflows and increase the cost of betting against the rupee, according to bankers and analysts cited by Reuters. The measures follow recent rate increases and steps to drain liquidity as pressure on the currency and inflation concerns persist
  • India directed oil marketing companies to stop diverting sugar-based feedstocks for ethanol production in the 2026–27 supply year, according to a new tender issued on Friday. The companies have invited bids for 11 billion litres of ethanol made from alternatives including corn and broken rice, amid concerns about domestic sugar supplies and prices
  • Finance Minister Nirmala Sitharaman said India's trade imbalance with China was growing sharply and attributed the problem partly to restrictions on Indian goods and services entering the Chinese market. China subsequently said it was ready to work with India to address mutual economic and trade concerns; India's trade deficit with China reached $69 billion in the first half of FY2026–27, up 27% year-on-year
  • Indian equity benchmarks extended their recovery on Friday, with the Sensex rising 413.66 points to close at 74,729.27 and the Nifty 50 gaining 148.80 points to settle at 23,146.15. Information technology shares, including Tech Mahindra, Infosys and TCS, helped lift the indices
  • India defeated Zimbabwe by four wickets in the opening women's T20 International in Raipur, taking a 1–0 lead in the three-match series. Deepti Sharma and Niki Prasad combined in an 82-run stand after India's top order collapsed, helping the hosts chase down Zimbabwe's total of 114 for five
  • Indian wrestler Komal won bronze in the women's 59 kg category at the Under-23 World Wrestling Championships in Las Vegas, defeating Kazakhstan's Viktoriia Khusainova 7–2. Fellow Indian Amruta Pujari advanced to the women's 72 kg final after recording two pinfall victories
  • Indian shuttler Jagsher Singh Khangurra secured a bronze medal at the BWF World Junior Badminton Championships in Cairo
  • The Supreme Court of India upheld the Bombay High Court's decision quashing the 2020 write-off of ₹8,415 crore in additional tier-1 bonds issued by Yes Bank (Yes Bank). The court ruled that the bank's administrator lacked the authority to extinguish the bonds under the final reconstruction scheme, strengthening bondholders' claims
  • The Supreme Court issued notices to the Election Commission of India, Delhi Police and opposition leaders, including Rahul Gandhi and Akhilesh Yadav, in separate petitions concerning electoral-roll revision and protests held in Delhi on October 10–12. The court also directed the preservation of CCTV footage linked to allegations of police excesses
  • The Supreme Court ruled that a person converting from Hinduism to Islam cannot automatically claim backward-class reservation benefits in the new religious community solely on the basis of their previous caste status. The judgment upheld the Madras High Court's decision striking down a 2024 Tamil Nadu government order that permitted such certification for specified communities
  • The Election Commission of India ordered a Special Summary Revision of electoral rolls in 14 states and three Union Territories, using January 1, 2027, as the qualifying date for voter eligibility. The draft rolls are scheduled for publication on November 12, claims and objections will be accepted until December 11, and the final rolls are due on January 4, 2027
Delhi HC refuses to ban CJP's Tiranga rally at Central Park in Connaught Place today /////// Police says will control and regulate it /////// NDMC closes the park for the public on Friday and Saturday
oppn parties
WHO Alert For Contaminated Syrups: India's Reputation As The Pharmacy Of The World Is At Stake

By A Special Correspondent
First publised on 2022-10-07 02:19:42

Gambia has recalled the four Indian cough syrups manufactured by Sonepat, Haryana-based Maiden Pharmaceuticals from pharmacies after the WHO alert that the syrups were, probably (pending detailed analysis), responsible for the death of 66 children in that country. The syrups were allegedly found to have a combination of several drugs some of which were found to exceed the permissible limits which probably led to the death of the children. WHO has recommended that the drug regulator in the originating country, meaning India, should conduct a thorough probe to find out the truth.

Basically, the WHO alert means that India will have to probe three things - whether the company was licensed to manufacture and export the alleged combinations; to which countries did the company export the products (and whether they were sold in any country other than where exported, through transshipment or otherwise) and whether the company did use certain chemicals beyond permissible limits as alleged.

The Indian authorities have issued a preliminary statement that said that the charged company had been permitted to manufacture the syrups for export only and not for sale in India. It also added that as per available data, the syrups had been exported only to Gambia. But that is not the only brief that the drug regulator in India should be seized with. In its alert, WHO said that the syrups were "substandard (contaminated) paediatric medicines". India needs to conduct a thorough probe. It has been reported that the samples have been sent for testing and the report will be out in two days.

It is not for nothing that India is called the pharmacy of the world. Indian drug manufacturers are renowned and respected for manufacturing good generic medicines that are used all over the world. One bad fish can spoil the reputation and severely dent the goodwill generated through ethical practices followed by drug manufacturers for years. Hence, it is in the interest of India to probe Maiden Pharmaceuticals and inspect its manufacturing facilities to discover the truth. The said company should be handed the maximum punishment prescribed by law to deter others and protect India's hard-earned reputation if it is found guilty.